BHMC-CONWAY
1. Target Overview & Investment Thesis
BHMC-CONWAY is a 108-bed under-performing / distressed in FAULKNER, AR with $94.7M in net patient revenue and a -15.6% operating margin. The hospital serves a payer mix of 40.3% Medicare, 8.6% Medicaid, and 51.1% commercial.
Thesis: Undervalued. Our ML models identify $7.0M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -15.6% to -8.2% (+736bps).
| Net Revenue HCRIS | $94.7M |
| Current EBITDA COMPUTED | $-14.8M |
| Operating Margin COMPUTED | -15.6% |
| Occupancy HCRIS | 45.6% |
| Revenue / Bed COMPUTED | $877K |
| Net-to-Gross HCRIS | 23.3% |
| Distress Probability ML | 50.6% |
2. Market Context & Competitive Position
AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of -15.6% places it below the state median. Among 31 size-comparable peers (54-216 beds), the median margin is 1.0%. The target's below-peer margin suggests operational improvement opportunity.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (54-216), prioritizing same-state peers. 31 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| BHMC-CONWAY (Target) | AR | 108 | $94.7M | -15.6% |
| BAXTER REGIONAL MEDICAL CENTER | AR | 169 | $282.2M | -2.8% |
| BAPTIST HEALTH MEDICAL CENTER- | AR | 200 | $278.0M | 0.2% |
| WHITE COUNTY MEDICAL CENTER | AR | 179 | $251.3M | 3.4% |
| WHITE RIVER MEDICAL CENTER | AR | 170 | $247.7M | -11.9% |
| NEA BAPTIST MEMORIAL HOSPITAL | AR | 180 | $246.7M | 1.0% |
| CONWAY REGIONAL MEDICAL CENTER | AR | 169 | $232.9M | -14.5% |
| ARKANSAS HEART HOSPITAL | AR | 112 | $205.9M | 1.2% |
| NATIONAL PARK MEDICAL CENTER | AR | 126 | $118.8M | 2.6% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $7.0M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $2.0M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.9M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.9M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.2M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $61K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $-14.8M |
| + RCM Uplift | +$7.0M |
| Pro Forma EBITDA | $-7.8M |
| Current Margin | -15.6% |
| Pro Forma Margin | -8.2% |
| WC Released (1x) | $3.6M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $-22.7M | $-27.6M | 0.00x | -100.0% |
| Base (11x exit) | 10.0x | 11.0x | $-22.7M | $-37.7M | 0.00x | -100.0% |
| Bull Case | 9.0x | 11.0x | $-20.4M | $-22.1M | 0.00x | -100.0% |
| Bull (12x exit) | 9.0x | 12.0x | $-20.4M | $-30.1M | 0.00x | -100.0% |
| Bear Case | 11.0x | 10.0x | $-25.0M | $-55.1M | 0.00x | -100.0% |
| Bear (11x exit) | 11.0x | 11.0x | $-25.0M | $-68.7M | 0.00x | -100.0% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| High | Negative operating margin | RCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion |
| High | Elevated distress probability | Model estimates 50.6% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 31 hospitals with 54-216 beds
- Same-state prioritization (n=32)
- Comp margins: P25=-11.8% / P50=1.0% / P75=6.9%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.